Related references
Note: Only part of the references are listed.On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA)
Petar M. Mitrasinovic
BIOPHYSICAL CHEMISTRY (2009)
QSAR study of imidazoline antihypertensive drugs
Katarina Nikolic et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
5-caffeoylquinic acid and caffeic acid down-regulate the oxidative stress- and TNF-α-induced secretion of interleukin-8 from caco-2 cells
Zhaohui Zhao et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2008)
Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus
Qi-Shi Du et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Antibacterial activity of coffee extracts and selected coffee chemical compounds against enterobacteria
Ana Amelia P. Almeida et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2006)
Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid
Michel David dos Santos et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
Rupert J. Russell et al.
NATURE (2006)
Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors
VP Mishin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Inhibition of activator protein-1, NF-κB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid
RT Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic
P Ward et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Chlorogenic acid-inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells
G Bandyopadhyay et al.
BLOOD (2004)
Absorption of phenolic acids in humans after coffee consumption
M Nardini et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2002)
Resistance of influenza viruses to neuraminidase inhibitors - a review
JL McKimm-Breschkin
ANTIVIRAL RESEARCH (2000)
Discovery and development of GS 4104 (oseltamivir): An orally active influenza neuraminidase inhibitor
W Lew et al.
CURRENT MEDICINAL CHEMISTRY (2000)
Share Paper
